Angus JA - Search Results

1

PI 3-kinase p110beta: a new target for antithrombotic therapy.

Jackson SP, Schoenwaelder SM, Goncalves I, Nesbitt WS, Yap CL, Wright CE, Kenche V, Anderson KE, Dopheide SM, Yuan Y, Sturgeon SA, Prabaharan H, Thompson PE, Smith GD, Shepherd PR, Daniele N, Kulkarni S, Abbott B, Saylik D, Jones C, Lu L, Giuliano S, Hughan SC, Angus JA, Robertson AD, Salem HH. Jackson SP, et al. Among authors: angus ja. Nat Med. 2005 May;11(5):507-14. doi: 10.1038/nm1232. Epub 2005 Apr 17. Nat Med. 2005. PMID: 15834429 Free article.

2

Advantages of a selective beta-isoform phosphoinositide 3-kinase antagonist, an anti-thrombotic agent devoid of other cardiovascular actions in the rat.

Sturgeon SA, Jones C, Angus JA, Wright CE. Sturgeon SA, et al. Among authors: angus ja. Eur J Pharmacol. 2008 Jun 10;587(1-3):209-15. doi: 10.1016/j.ejphar.2008.03.017. Epub 2008 Mar 29. Eur J Pharmacol. 2008. PMID: 18455722

3

Adaptation of the Folts and electrolytic methods of arterial thrombosis for the study of anti-thrombotic molecules in small animals.

Sturgeon SA, Jones C, Angus JA, Wright CE. Sturgeon SA, et al. Among authors: angus ja. J Pharmacol Toxicol Methods. 2006 Jan-Feb;53(1):20-9. doi: 10.1016/j.vascn.2005.06.006. Epub 2005 Aug 8. J Pharmacol Toxicol Methods. 2006. PMID: 16087355

4

Diverse vascular responses to serotonin in the conscious rabbit: effects of serotonin antagonists on renal artery spasm.

Wright CE, Angus JA. Wright CE, et al. Among authors: angus ja. J Cardiovasc Pharmacol. 1987 Oct;10(4):415-23. doi: 10.1097/00005344-198710000-00006. J Cardiovasc Pharmacol. 1987. PMID: 2444794

5

5-carboxamidotryptamine elicits 5-HT2 and 5-HT3 receptor-mediated cardiovascular responses in the conscious rabbit: evidence for 5-HT release from platelets.

Wright CE, Angus JA. Wright CE, et al. Among authors: angus ja. J Cardiovasc Pharmacol. 1989 Apr;13(4):557-64. J Cardiovasc Pharmacol. 1989. PMID: 2470992

6

Letter by Angus and Wright Regarding Article, "Pannexin-1 Channels as an Unexpected New Target of the Antihypertensive Drug Spironolactone".

Angus JA, Wright CE. Angus JA, et al. Circ Res. 2018 May 25;122(11):e86-e87. doi: 10.1161/CIRCRESAHA.118.313062. Circ Res. 2018. PMID: 29798904 No abstract available.

7

Hemodynamic and autonomic reflex effects of chronic N-type Ca2+ channel blockade with omega-conotoxin GVIA in conscious normotensive and hypertensive rabbits.

Wright CE, Angus JA. Wright CE, et al. Among authors: angus ja. J Cardiovasc Pharmacol. 1995 Mar;25(3):459-68. doi: 10.1097/00005344-199503000-00017. J Cardiovasc Pharmacol. 1995. PMID: 7769813

8

Enhanced total peripheral vascular responsiveness in hypertension accords with the amplifier hypothesis.

Wright CE, Angus JA. Wright CE, et al. Among authors: angus ja. J Hypertens. 1999 Dec;17(12 Pt 1):1687-96. doi: 10.1097/00004872-199917120-00005. J Hypertens. 1999. PMID: 10658934

9

Techniques to measure pharmacodynamics in the intact vasculature.

Wright CE, Angus JA. Wright CE, et al. Among authors: angus ja. J Pharmacol Toxicol Methods. 2000 Sep-Oct;44(2):385-94. doi: 10.1016/s1056-8719(00)00122-2. J Pharmacol Toxicol Methods. 2000. PMID: 11325581 Review.

10

Techniques to study the pharmacodynamics of isolated large and small blood vessels.

Angus JA, Wright CE. Angus JA, et al. J Pharmacol Toxicol Methods. 2000 Sep-Oct;44(2):395-407. doi: 10.1016/s1056-8719(00)00121-0. J Pharmacol Toxicol Methods. 2000. PMID: 11325582 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

231 results

Search Page